New single-tablet option for hepatitis C

Zepatier (elbasvir/grazoprevir) is a once-daily, single-tablet treatment for chronic hepatitis C in adults.

by Tulsi Pindolia
The two direct-acting antivirals in Zepatier target the hepatitis C virus at different stages in its lifecycle. | SCIENCE PHOTO LIBRARY
The two direct-acting antivirals in Zepatier target the hepatitis C virus at different stages in its lifecycle. | SCIENCE PHOTO LIBRARY

Sign in to continue

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now

Subscribe now

Benefits include:

  • Full site access
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a package